Interactions between Benadryl and Duloxetine
Taking Benadryl (diphenhydramine) and Duloxetine together can lead to increased risks and potential side effects.
Combination Risks
The combination of diphenhydramine and duloxetine [2] can cause significant drowsiness, sedation, and cognitive impairment due to the additive anticholinergic effects of diphenhydramine [3]. This can impair your ability to perform daily tasks and increase the risk of falls. Moreover, duloxetine is an SNRI (serotonin-norepinephrine reuptake inhibitor) antidepressant that can have complex interactions with other medications.
Serotonin Syndrome
Combining diphenhydramine with duloxetine increases the risk of serotonin syndrome, a potentially life-threatening condition caused by excessive serotonin levels in the body [4]. This can occur due to the serotonergic activity of duloxetine and the antihistamine effects of diphenhydramine.
What happens if I stop taking them suddenly?
Sudden withdrawal from duloxetine can lead to unpleasant side effects, including dizziness, headaches, and nausea. Stopping diphenhydramine abruptly may not cause significant issues, but it can still lead to withdrawal symptoms, such as insomnia and tremors.
Alternatives and Consultation
Consult your healthcare provider before taking Benadryl and Duloxetine together, especially if you are taking other medications or have any pre-existing medical conditions. They can help you weigh the risks and benefits of this combination and recommend alternative treatments.
Drug Interactions and Safety
According to the FDA [5] and DrugPatentWatch.com [1], it's essential to be cautious when combining medications, especially those with potential interactions. Always follow your healthcare provider's instructions and take medications as prescribed.
Sources:
[1] DrugPatentWatch.com
[2] RxList. Compendium of select drug and dosing information.
[3] PubMed. Journal of Clinical Psychopharmacology. Diphenhydramine and the anticholinergic effect on cognitive function.
[4] Medline Plus. Serotonin Syndrome
[5] Food and Drug Administration (FDA).
Cited sources: [1], [2], [3], [4], [5]